Core Viewpoint - Procter & Gamble (PG) has experienced a significant rise in stock price, reaching a new 52-week high, but faces challenges in key markets and a potentially unsustainable valuation [1][7]. Group 1: Stock Performance - PG shares hit a 52-week high of $170.17 before closing at $169.44, trading above both the 50-day and 200-day simple moving averages [1]. - Over the past year, PG's shares have increased by 12.8%, outperforming the broader industry which rose by 11.4%, while the Zacks Consumer Staples sector declined by 4.4% [1]. - In the last three months, PG's stock gained 7.6%, lagging behind the industry's 10.5% improvement, and in the past month, it showed a growth of only 1% compared to the industry's 1.1% rise [4]. Group 2: Business Model and Operations - PG operates in over 180 countries, providing a diversified revenue base that allows it to leverage growth in emerging markets while maintaining steady income from developed regions [2]. - The company has a wide-ranging portfolio of brands, including Tide, Gillette, Pampers, and Crest, which fosters strong brand loyalty and enables premium pricing [3]. - PG's focus on productivity and cost-saving initiatives has helped expand margins despite inflationary pressures, with the supply-chain 3.0 program enhancing productivity and scalability [3]. Group 3: Market Challenges - Organic sales in Greater China declined by 10% year over year, with brands like SK-II experiencing a 30% drop in sales, indicating challenges in the luxury skincare segment [5]. - Emerging markets in the Asia Pacific, Middle East, and Africa are facing soft volume trends due to geopolitical tensions affecting consumer spending [5]. - Currency volatility is expected to have a significant aftertax impact of $600 million for fiscal 2024, posing financial headwinds for PG [6]. Group 4: Valuation Concerns - PG is currently trading at a forward 12-month P/E multiple of 24.24X, which is above the industry average of 23X and the S&P 500's average of 22.07X, indicating a potentially unsustainable valuation [7]. - The premium valuation relative to industry peers raises concerns about the sustainability of PG's stock performance amid increasing competition and economic uncertainties [9].

Procter & Gamble (PG) closed the latest trading day at $166.95, indicating a +1.44% change from the previous session's end. This change outpaced the S&P 500's 0.64% gain on the day. Meanwhile, the Dow experienced a rise of 1.85%, and the technology-dominated Nasdaq saw an increase of 0.2%.Shares of the world's largest consumer products maker witnessed a loss of 1.74% over the previous month, trailing the performance of the Consumer Staples sector with its gain of 0.85% and the S&P 500's gain of 3.82%.Analys ...

In the latest trading session, Procter & Gamble (PG) closed at $166.52, marking a +0.79% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.1%. Meanwhile, the Dow experienced a drop of 0.08%, and the technology-dominated Nasdaq saw an increase of 0.28%.The world's largest consumer products maker's stock has dropped by 1.11% in the past month, exceeding the Consumer Staples sector's loss of 2% and lagging the S&P 500's gain of 4.08%.Analysts and investors alike wil ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Procter & Gamble (PG) .P&G currently has an average brokerage recommendation (ABR) of 1.59, on ...

Vertigo3d Investment thesis To avoid any misunderstandings - I own a certain position in Procter & Gamble (NYSE:PG), and I don't intend to sell it. It's an amazing business with a shareholder-friendly approach. I highly appreciate the dividends that grew over the years and don't see any "sell" rationale. Considering PG's: headwinds limiting (to some degree) its growth its improved yet below competitors' level organic volume growth its ability to uphold positive growth outstanding profitability leadership p ...

Core Viewpoint - Procter & Gamble (P&G) is currently experiencing a mixed performance in the stock market, with a recent return of +2.5% over the past month, lagging behind the S&P 500's +3.5% and the Soap and Cleaning Materials industry's +1.4% [1] Earnings Estimates - For the current quarter, P&G is expected to report earnings of $1.37 per share, unchanged from the previous year [3] - The consensus earnings estimate for the current fiscal year is $6.55, reflecting an increase of +11% from the prior year, with no change in the estimate over the last 30 days [3] - For the next fiscal year, the consensus estimate is $6.97, indicating a +6.3% change from the expected report a year ago, also remaining unchanged over the past month [3] - P&G holds a Zacks Rank 2 (Buy), indicating a favorable outlook based on earnings estimate revisions [3] Revenue Growth - The consensus sales estimate for the current quarter is $20.81 billion, representing a year-over-year increase of +1.3% [5] - For the current fiscal year, the sales estimate is $84.32 billion, indicating a +2.8% change, while the next fiscal year's estimate is $87.18 billion, reflecting a +3.4% change [5] Last Reported Results - In the last reported quarter, P&G generated revenues of $20.2 billion, a +0.6% increase year-over-year [6] - The EPS for the same period was $1.52, compared to $1.37 a year ago, with a revenue surprise of -1.41% against the Zacks Consensus Estimate [6] - P&G has consistently beaten consensus EPS estimates in the last four quarters and topped revenue estimates twice during this period [6] Valuation - P&G is graded D in terms of valuation, indicating it is trading at a premium compared to its peers [9] - The Zacks Value Style Score system assesses stocks based on various valuation metrics, helping to identify whether a stock is overvalued, rightly valued, or temporarily undervalued [8] Conclusion - The information presented suggests that P&G may outperform the broader market in the near term, supported by its Zacks Rank 2 [10]

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.The Zacks Premium service, which provides daily updates of the Zacks Rank and Zacks Industry Rank; full access to the Zacks #1 Rank List; Equity Research reports; and Premium stock screens like the Earnings ESP filter, makes these more manageable goals. All of the features can help you identify what stocks to buy, what to sell, and what ...

Procter & Gamble (PG) closed the most recent trading day at $166.85, moving -0.95% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.09% for the day. Elsewhere, the Dow lost 0.1%, while the tech-heavy Nasdaq added 0.16%. Shares of the world's largest consumer products maker have appreciated by 1.89% over the course of the past month, outperforming the Consumer Staples sector's loss of 0.36% and lagging the S&P 500's gain of 2.83%. The upcoming earnings rele ...

Core Viewpoint - Wall Street analysts' recommendations, particularly for Procter & Gamble (PG), show a strong positive bias, which may not align with actual stock performance, suggesting that investors should validate these recommendations with their own research [1][2][4]. Brokerage Recommendation Summary - Procter & Gamble has an average brokerage recommendation (ABR) of 1.61, indicating a consensus between Strong Buy and Buy, with 14 Strong Buy and 2 Buy recommendations from 22 brokerage firms [1]. - Strong Buy and Buy recommendations account for 63.6% and 9.1% of total recommendations, respectively [1]. Zacks Rank Comparison - The Zacks Rank, which is based on earnings estimate revisions, provides a more reliable indicator of near-term stock performance compared to ABR, which is influenced by brokerage analysts' biases [3][5]. - The Zacks Rank for PG is currently 3 (Hold), indicating a cautious outlook despite the positive ABR [6]. Earnings Estimate Insights - The Zacks Consensus Estimate for PG's earnings remains unchanged at $6.55, suggesting stability in analysts' views on the company's earnings prospects [6]. - The unchanged consensus estimate contributes to the Zacks Rank 3 for PG, indicating potential performance in line with the broader market [6].

ARLINGTON, Va., June 13, 2024 /PRNewswire/ -- March of Dimes, the leading nonprofit fighting for the health of all families, has awarded its 2024 March of Dimes Nursing Scholarship Awards to two outstanding nurses for their undergraduate and graduate studies. Established in 1998, the award recognizes and promotes excellence in nursing and furthers the organization's commitment to closing the health equity gap and ensuring all moms and babies receive the highest quality of medical care. Both winners will rec ...